Information
-
Trademark
-
79411051
-
International Classifications
-
Filing Date
October 16, 2024
2 months ago
-
Transaction Date
December 06, 2024
16 days ago
-
Status Date
November 28, 2024
24 days ago
-
Location Date
December 06, 2024
16 days ago
Mark Drawing Code
4
Mark Identification
STEZYLDA
Case File Statements
- GS0051: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.
Case File Event Statements
-
11/28/2024 - 24 days ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
12/6/2024 - 16 days ago
2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED
Type: LIMI
-
12/6/2024 - 16 days ago
3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
12/6/2024 - 16 days ago
4 - APPLICATION FILING RECEIPT MAILED
Type: MAFR